Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Neutrophils are a characteristic feature of the alveolitis of idiopathic pulmonary fibrosis (IPF). a chronic disorder limited to lung. One mechanism by which neutrophils may be selectively attracted to lung and not other tissues is via the secretion of the neutrophil-specific chemotactic factor by alveolar macrophages. To evaluate the role of alveolar macrophages in modulating the migration of neutrophils to he lung in IPF, alveolar macrophages, obtained by bronchoalveolar lavage of patients with IPF, were evaluated for their ability to release a chemotactic factor for neutrophils. Unstimulated alveolar macrophages from normal individuals did not release the factor. In patients with IPF, there was a significant correlation between the proportions of neutrophils in lavage fluid and the release of a chemotactic factor for neutrophils by alveolar macrophages (p less than 0.001). The chemotactic factor released by IPF alveolar macrophages was of low molecular weight (400-600), at least partially lipid in nature, and preferentially attracted neutrophils compared with monocytes. Several lines of evidence suggested that immune complexes in the lung stimulated alveolar macrophages of patients with IPF to release the chemotactic factor. First, immune complexes stimulated normal macrophages to release the factor.Second, there was a significant correlation between the release of the chemotactic factor by IPF alveolar macrophages and the levels of immune complexes in bronchoalveolar lavage fluid. Third, bronchoalveolar lavage fluid containing immune complexes stimulated normal macrophages to release the factor. Fourth, IPF alveolar macrophages that released large amounts of the chemotactic factor had an apparent suppression of their immunoglobulin (Ig)G Fc receptor function, suggesting that immune complexes were bound to their surface. In contrast, the IgG Fc receptor function of IPF alveolar macrophages that released only small amounts of the factor was similar to that of normal macrophages. These studies suggest that neutrophils are attracted to the lung in patients with IPF by a potent chemotactic factor released by alveolar macrophages that have been stimulated, in vivo, via their IgG Fc receptor by immune complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Hunninghake, G. W., Gadek, J. E., Kawanami, O., Ferrans, V. J., & Crystal, R. G. (1979) · PubMed Central · Cited by 1,013
Self-citationZubler, R. H., Lange, G. T., Lambert, P. H., & Miescher, P. A. (1976) · PubMed · Cited by 717
CRYSTAL, R. G., FULMER, J. D., ROBERTS, W. C., MOSS, M. L., LINE, B. R., & REYNOLDS, H. Y. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-6-769 · Cited by 685
Self-citationFernández, H. N., Henson, P. M., Otani, A., & Hugli, T. E. (1978) · PubMed · Cited by 567
Reynolds, H. Y., Fulmer, J. D., Kazmierowski, J. A., Roberts, W. C., Frank, M. M., & Crystal, R. G. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108615 · Cited by 557 · cited 4×
“Because protein concentrations in lavage fluid are dependent upon the degree of dilution of the epithelial lining fluid by the infused saline and upon the concentration of the fluid by membrane filtration, albumin was used as a standard for comparison of other protein components (7, 12, 25).”
BackgroundMethodInfluentialSelf-citationInterstitial lung disease: Current concepts of pathogenesis, staging and therapy
Crystal, R. G., Gadek, J. E., Ferrans, V. J., Fulmer, J. D., Line, B. R., & Hunninghake, G. W. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90577-5 · Cited by 547 · cited 8×
“In contrast to the increased numbers of neutrophils in the IPF lung, the relative proportions of various other lung inflammatory and immune effector cell populations, including alveolar macrophages, T lymphocytes, and B lymphocytes, are normal (11-16).”
BackgroundMethodInfluentialSelf-citationTHE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO
Ward, P. A., Cochrane, C. G., & Müller-Eberhard, H. J. (1965) · The Journal of Experimental Medicine · doi:10.1084/jem.122.2.327 · Cited by 400 · cited 1×
“Although it is clear that alveolar macrophages of some IPF patients release large amounts of a potent chemotactic factor for neutrophils, it is possible that other chemotactic factors, such as the complementderived chemotactic factors, are also generated as a result of the presence of immune complexes in lung as well…”
BackgroundScadding, J. G., & Hinson, K. F. W. (1967) · Thorax · doi:10.1136/thx.22.4.291 · Cited by 303
Bronchoalveolar Lavage in Interstitial Lung Disease
WEINBERGER, S. E., KELMAN, J. A., ELSON, N. A., YOUNG, R. C., REYNOLDS, H. Y., FULMER, J. D., & CRYSTAL, R. G. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-4-459 · Cited by 293 · cited 8×
“In contrast to the increased numbers of neutrophils in the IPF lung, the relative proportions of various other lung inflammatory and immune effector cell populations, including alveolar macrophages, T lymphocytes, and B lymphocytes, are normal (11-16).”
BackgroundMethodInfluentialSelf-citationCirculating Immune Complexes in the Idiopathic Interstitial Pneumonias
Dreisin, R. B., Schwarz, M. I., Theofilopoulos, A. N., & Stanford, R. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197802162980701 · Cited by 278 · cited 2×
“active SLE and active IPF have circulating immune complexes (37, 38), these observations also suggest that either not all circulating immune complexes reach the surface of the alveolar macrophage, or that cer-”
BackgroundHuman Alveolar Macrophage-derived Chemotactic Factor for Neutrophils
Hunninghake, G. W., Gadek, J. E., Fales, H. M., & Crystal, R. G. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109878 · Cited by 251
Self-citationMerrill, W. W., Naegel, G. P., Matthay, R. A., & Reynolds, H. Y. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109668 · Cited by 228
Hunninghake, G. W., Kawanami, O., Ferrans, V. J., Young, R. C., Roberts, W. C., & Crystal, R. G. (1981) · PubMed · doi:10.1164/arrd.1981.123.4.407 · Cited by 227
Self-citationINTERACTIONS OF THE COMPLEMENT SYSTEM WITH ENDOTOXIC LIPOPOLYSACCHARIDE
Snyderman, R., Gewurz, H., & Mergenhagen, S. E. (1968) · The Journal of Experimental Medicine · doi:10.1084/jem.128.2.259 · Cited by 218
Kazmierowski, J. A., Gallin, J. I., & Reynolds, H. Y. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108638 · Cited by 209
Collagenase in the Lower Respiratory Tract of Patients with Idiopathic Pulmonary Fibrosis
Gadek, J. E., Kelman, J. A., Fells, G., Weinberger, S. E., Horwitz, A. L., Reynolds, H. Y., Fulmer, J. D., & Crystal, R. G. (1979) · New England Journal of Medicine · doi:10.1056/nejm197910043011401 · Cited by 205
Self-citationGranulocyte collagenase: selective digestion of type I relative to type III collagen.
Horwitz, A. L., Hance, A. J., & Crystal, R. G. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.3.897 · Cited by 204
Self-citationThe connective tissue of lung.
Hance, A. J., & Crystal, R. G. (1975) · PubMed · doi:10.1164/arrd.1975.112.5.657 · Cited by 168
Self-citationSnyderman, R., Phillips, J., & Mergenhagen, S. E. (1970) · Infection and Immunity · doi:10.1128/iai.1.6.521-525.1970 · Cited by 167 · cited 1×
“Although it is clear that alveolar macrophages of some IPF patients release large amounts of a potent chemotactic factor for neutrophils, it is possible that other chemotactic factors, such as the complementderived chemotactic factors, are also generated as a result of the presence of immune complexes in lung as well…”
BackgroundComplement fragments, alveolar macrophages, and alveolitis.
Henson, P. M., McCarthy, K. M., Larsen, G. L., Webster, R. O., Giclas, P. C., Dreisin, R. B., King, T. E., & Shaw, J. O. (1979) · PubMed · Cited by 138
Hunninghake, G. W., Gallin, J. I., & Fauci, A. S. (1978) · PubMed · doi:10.1164/arrd.1978.117.1.15 · Cited by 131 · cited 1×
“One of the means by which neutrophils may be selectively attracted to the lung is by the release of a neutrophil-specific chemotactic factor by alveolar macrophages (17-23).”
BackgroundSelf-citationGriffin, F. M. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.4.905 · Cited by 81
Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor.
Gadek, J. E., Hunninghake, G. W., Zimmerman, R. L., & Crystal, R. G. (1980) · PubMed · doi:10.1164/arrd.1980.121.4.723 · Cited by 79 · cited 3×
“However, even if these complement-derived chemotactic factors are generated in the lung in IPF, it is possible that the primary effect of these factors on neutrophil migration to the lung is mediated via stimulation of alveolar macrophages to release the macrophage-derived chemotactic factor (21-22).”
BackgroundSelf-citationInterstitial associations of cells lining air spaces in human pulmonary fibrosis
Brody, A. R., & Craighead, J. E. (1976) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00429715 · Cited by 43
Spencer, H. (1967) · Annual Review of Medicine · doi:10.1146/annurev.me.18.020167.002231 · Cited by 38
Immunological reactivity of the lung
Hunninghake, G. W., & Fauci, A. S. (1977) · Cellular Immunology · doi:10.1016/0008-8749(77)90197-6 · Cited by 25 · cited 7×
“PHA-coated ORBCwere used as additional targets since killing of these cells is mediated by alveolar macrophages, but not via the macrophage IgG-Fc receptor (28,29).”
BackgroundMethodInfluentialSelf-citation
Cited by
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Macrophages and Polymorphonuclear Neutrophils in Lung Defense and Injury
Sibille, Y., & Reynolds, H. Y. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.471 · Cited by 1,083
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
“Indeed neutrophilia is a com mon feature of fibrosis and pulmonary alveolitis in IPF patients (Hunninghake et al., 1981; Kinder et al., 2008), with airway neutrophilia identified as a predictor of early mortality in IPF (Kinder et al.”
BackgroundInfluentialCrystal, R. G., Bitterman, P. B., Rennard, S. I., Hance, A. J., & Keogh, B. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100304 · Cited by 690
Self-citation
Metadata
- Authors
- Hunninghake, G. W., Gadek, J. E., Lawley, T. J., & Crystal, R. G.
- Venue
- Journal of Clinical Investigation
- Published
- 1981-07-01
- Volume
- 68
- Issue
- 1
- Pages
- 259-269
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1965755176
- Cited by
- 239
- References
- 28
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.